Yaosen Min
Research Subjects
Research Interests
Yaosen Min has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Ji Wu
Tsinghua University
2 shared publications - Dan Zhao
Tsinghua University
1 shared publication Han Li
Institute for Interdisciplinary Information Sciences Tsinghua University Beijing 100084 China
1 shared publication- Jianyang Zeng
School of Engineering, Westlake University, Hangzhou, China
1 shared publication - Jiaxi Wang
Department of Electronic Engineering, Tsinghua University, Beijing, China
1 shared publication - Miao Li
Department of Electronic Engineering, Tsinghua University, Beijing, China
1 shared publication
Latest Publications
- Open Access
- 27 October 2025
- Published by Association for Computing Machinery (ACM)
- p. 729-738
MIPS: A Multimodal Infinite Polymer Sequence Pre-training Framework for Polymer Property Prediction
- 27 October 2025
- Published by Association for Computing Machinery (ACM)
- p. 729-738
Open AccessMIPS: A Multimodal Infinite Polymer Sequence Pre-training Framework for Polymer Property Prediction
- Open Access
- 29 August 2024
- Published by Wiley in Advanced Science
- Vol. 11 (40) , e2405404
From Static to Dynamic Structures: Improving Binding Affinity Prediction with Graph‐Based Deep Learning
Accurate prediction of protein‐ligand binding affinities is an essential challenge in structure‐based drug design. Despite recent advances in data‐driven methods for affinity prediction, their accuracy is still limited, partially because they only take advantage of static crystal structures while the actual binding affinities are generally determined by the thermodynamic ensembles between proteins and ligands. One effective way to approximate such a thermodynamic ensemble is to use molecular dynamics (MD) simulation. Here, an MD dataset containing 3,218 different protein‐ligand complexes is curated, and Dynaformer, a graph‐based deep learning model is further developed to predict the binding affinities by learning the geometric characteristics of the protein‐ligand interactions from the MD trajectories. In silico experiments demonstrated that the model exhibits state‐of‐the‐art scoring and ranking power on the CASF‐2016 benchmark dataset, outperforming the methods hitherto reported. Moreover, in a virtual screening on heat shock protein 90 (HSP90) using Dynaformer, 20 candidates are identified and their binding affinities are further experimentally validated. Dynaformer displayed promising results in virtual drug screening, revealing 12 hit compounds (two are in the submicromolar range), including several novel scaffolds. Overall, these results demonstrated that the approach offer a promising avenue for accelerating the early drug discovery process.
- 29 August 2024
- Published by Wiley in Advanced Science
- Vol. 11 (40) , e2405404
Open AccessFrom Static to Dynamic Structures: Improving Binding Affinity Prediction with Graph‐Based Deep Learning
Accurate prediction of protein‐ligand binding affinities is an essential challenge in structure‐based drug design. Despite recent advances in data‐driven methods for affinity prediction, their accuracy is still limited, partially because they only take advantage of static crystal structures while the actual binding affinities are generally determined by the thermodynamic ensembles between proteins and ligands. One effective way to approximate such a thermodynamic ensemble is to use molecular dynamics (MD) simulation. Here, an MD dataset containing 3,218 different protein‐ligand complexes is curated, and Dynaformer, a graph‐based deep learning model is further developed to predict the binding affinities by learning the geometric characteristics of the protein‐ligand interactions from the MD trajectories. In silico experiments demonstrated that the model exhibits state‐of‐the‐art scoring and ranking power on the CASF‐2016 benchmark dataset, outperforming the methods hitherto reported. Moreover, in a virtual screening on heat shock protein 90 (HSP90) using Dynaformer, 20 candidates are identified and their binding affinities are further experimentally validated. Dynaformer displayed promising results in virtual drug screening, revealing 12 hit compounds (two are in the submicromolar range), including several novel scaffolds. Overall, these results demonstrated that the approach offer a promising avenue for accelerating the early drug discovery process.